Scientific evidence, regulatory decision making and incentives for therapeutics in infectious diseases: the example of cefiderocol.

Authors

John H. Powers III, George Washington University

Document Type

Journal Article

Publication Date

12-1-2020

Journal

Clinical Infectious Diseases

DOI

10.1093/cid/ciaa1795

Comments

Online ahead of print

APA Citation

Powers III, J. H. (2020). Scientific evidence, regulatory decision making and incentives for therapeutics in infectious diseases: the example of cefiderocol.. Clinical Infectious Diseases, (). http://dx.doi.org/10.1093/cid/ciaa1795

Peer Reviewed

1